| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H25N3O3S |
| Molar mass | 339.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
UK-414,495 is a drug developed byPfizer for the treatment offemale sexual arousal disorder. UK-414,495 acts as a potent, selective inhibitor of the enzymeneutral endopeptidase, which normally serves to break down theneuropeptideVIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation.[1][2][3]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |